Oliwia Kalinowska
Cosmetic Product Research Senior Specialist
J.S. Hamilton
Biography
Oliwia Kalinowska is an MPharm Senior Cosmetic Product Specialist, continuously expanding her expertise in dermatological testing, physicochemical methods for cosmetic analysis, application and instrumental studies, as well as the analysis and interpretation of research results. She is currently involved in study documentation, including SOPs, procedures, and clinical data management processes. She supports clients in selecting appropriate testing methodologies, with particular focus on their clinical relevance. She represents the company during meetings with international partners, where she discusses study protocols and provides guidance on tailoring the testing strategy to the specific needs of each product. Her background in pharmacy and computer science allows her to combine a scientific perspective and analytical approach with a practical understanding of product safety and efficacy.
Conference
Day 1
Session 2: Exposome impact on Skin & Hair
Approach to substantiating the claim: Protection against the impact of the exposome on hair cand scalp condition.
The categorization of exposome factors is an extremely complex topic. The purpose of this presentation is to contribute to the standardization of defining exosome factors, as well as to address the needs of the commercial testing market and support the process of cosmetic product development. Hair and scalp care products require an even more individualized approach in this type of research.
One of the approaches proposed by the J.S. Hamilton Laboratory for evaluating the effectiveness of a cosmetic product in protecting against the negative impact of exposome factors on the hair and scalp involves a series of tests that take into account scalp microbiome analysis, the antioxidant potential and pH of the cosmetic formulation, as well as the product’s thermoprotective properties and UV protection. This is a combination of in vitro, ex vivo, and in vivo evaluations, accompanied by clinical assessment by a dermatologist and a trichologist. Clinical evaluation combined with instrumental measurements allows for an in-depth, non-invasive investigation of exposome-related issues within the studied population.
Only if the cosmetic product proves effective in mitigating the effects of the exposome - its defined components - can we provide data supporting this claim.